Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Helfand

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal of Veterinary Internal Medicine|September 1, 1993
Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphomaE T Keller, E G MacEwen, R C Rosenthal, et al.
Journal of the American Veterinary Medical Association|February 1, 1994
Primary IgG secreting plasma cell tumor in the gastrointestinal tract of a dogM W Jackson, S C Helfand, S L Smedes, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 1994
Clinical and immunological effects of human recombinant interleukin-2 given by repetitive weekly infusion to normal dogsS C Helfand, S A Soergel, P S MacWilliams, et al.
Journal of Veterinary Internal Medicine|November 1, 1995
Response to liposome-encapsulated doxorubicin (TLC D-99) in a dog with myelomaW C Kisseberth, E G MacEwen, S C Helfand, et al.
Experimental Hematology|April 21, 1999
Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kitC A London, S J Galli, T Yuuki, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 5, 1999
The immunotherapeutic potential of activated canine alveolar macrophages and antitumor monoclonal antibodies in metastatic canine melanomaS A Soergel, E G MacEwen, D M Vail, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Potential to involve multiple effector cells with human recombinant interleukin-2 and antiganglioside monoclonal antibodies in a canine malignant melanoma immunotherapy modelS C Helfand, S A Soergel, R L Donner, et al.
Veterinary Pathology|September 8, 2005
Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcomaE B Dickerson, R Thomas, S P Fosmire, et al.
Blood|July 15, 1995
Functional interleukin-2 receptors are expressed on natural killer-like leukemic cells from a dog with cutaneous lymphomaS C Helfand, J F Modiano, P F Moore, et al.
Cancer Biotherapy|January 1, 1995
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine for the treatment of feline mammary adenocarcinoma--a multicenter randomized double-blind studyL E Fox, E G MacEwen, I D Kurzman, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Veterinary Internal Medicine|September 1, 1993
Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphomaE T Keller, E G MacEwen, R C Rosenthal, et al.
Journal of the American Veterinary Medical Association|February 1, 1994
Primary IgG secreting plasma cell tumor in the gastrointestinal tract of a dogM W Jackson, S C Helfand, S L Smedes, et al.
Cancer Immunology, Immunotherapy : CII|August 1, 1994
Clinical and immunological effects of human recombinant interleukin-2 given by repetitive weekly infusion to normal dogsS C Helfand, S A Soergel, P S MacWilliams, et al.
Journal of Veterinary Internal Medicine|November 1, 1995
Response to liposome-encapsulated doxorubicin (TLC D-99) in a dog with myelomaW C Kisseberth, E G MacEwen, S C Helfand, et al.
Experimental Hematology|April 21, 1999
Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kitC A London, S J Galli, T Yuuki, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 5, 1999
The immunotherapeutic potential of activated canine alveolar macrophages and antitumor monoclonal antibodies in metastatic canine melanomaS A Soergel, E G MacEwen, D M Vail, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1994
Potential to involve multiple effector cells with human recombinant interleukin-2 and antiganglioside monoclonal antibodies in a canine malignant melanoma immunotherapy modelS C Helfand, S A Soergel, R L Donner, et al.
Veterinary Pathology|September 8, 2005
Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcomaE B Dickerson, R Thomas, S P Fosmire, et al.
Blood|July 15, 1995
Functional interleukin-2 receptors are expressed on natural killer-like leukemic cells from a dog with cutaneous lymphomaS C Helfand, J F Modiano, P F Moore, et al.
Cancer Biotherapy|January 1, 1995
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine for the treatment of feline mammary adenocarcinoma--a multicenter randomized double-blind studyL E Fox, E G MacEwen, I D Kurzman, et al.
Pageof 4